United Neuroscience

14 articles about United Neuroscience

• 

  Alzheimer’s Vaccine Could Be on the Horizon

  10/27/2021

  Nuravax is developing an Alzheimer's vaccine to induce therapeutically potent concentrations of antibodies against pathological proteins. Know more here.

• COVAXX and United Neuroscience Are Now Vaxxinity

  4/1/2021

  COVAXX and United Neuroscience today announced the consolidation of their vaccine development efforts under the newly formed holding company, Vaxxinity, Inc.

• 

  COVAXX CEO Works to Redefine the Idea of a Vaccine

  1/13/2021

  The COVID-19 pandemic that has upended life across the globe has also ignited a reawakening to the value of vaccines, and Hu believes the momentum will carry forward into the new year.
• 

  Dallas/Ft. Worth: A “No-Brainer” for Life Science Development

  4/8/2019

  The recent CBRE Research report, “2019 U.S. Life Sciences Clusters” has two Texas metropolitan areas in its top-10 fastest-growing life sciences market. Houston ranked third, while Dallas/Ft. Worth ranked seventh. Let’s look at Dallas/Ft. Worth.

• United Neuroscience to Present Data on Alzheimer's Vaccine at the 2019 AD/PD Conference

  3/28/2019

  United Neuroscience announced an upcoming presentation on Phase IIa results of its lead clinical product, UB-311, at the 14th International Conference on Alzheimer's and Parkinson's Diseases in Lisbon, Portugal, from March 26-31, 2019.

• United Neuroscience Announces Positive Top-Line Results from Phase 2a Clinical Study of UB-311 Vaccine in Patients with Alzheimer's Disease

  1/16/2019

  United Neuroscience (UNS) announced positive top-line results from its Phase 2a clinical study of UB-311, a novel synthetic peptide vaccine targeting beta amyloid (Aβ) in the treatment of Alzheimer's disease

• United Neuroscience Names Peter Powchik, M.D, Executive Vice President of Research & Development

  12/21/2018

  United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brain disorders, today announced the appointment of Peter Powchik, M.D., to the newly created position of Executive Vice President of Research & Development effective Jan. 1, 2019.

• United Neuroscience Strengthens Vaccine Pipeline with Novel Immunotherapy for Parkinson's Disease

  11/13/2018

  Vaccine Targeted Against Aggregated Alpha-Synuclein Takes Aim at Parkinson's Disease

• United Neuroscience Continues Growth with Addition of Five Executives to Management Team

  10/16/2018

  United Neuroscience, Ltd. today announced five executive appointments as part of the company's continued expansion of the management team.

• United Neuroscience Announces Presentation at the 2018 Alzheimer's Association International Conference® (AAIC®)

  7/18/2018

  United Neuroscience, Ltd. announced that the company will present at the upcoming Alzheimer's Association International Conference (AAIC) being held July 22-26, 2018, in Chicago.

• United Neuroscience to Present at the Vatican's Pontifical Council for Culture and the Cura Foundation's Fourth International 'Unite To Cure' Conference in Vatican City

  4/27/2018

  United Neuroscience, Ltd., today announced that company co-founder Lou Reese will present at the Fourth International Conference, Unite to Cure: A Global Health Care Initiative, held April 26-28, 2018, at the Aula Nuova del Sinodo in Vatican City.

• United Neuroscience Signs Collaboration Agreement with French National Center for Scientific Research (CNRS) Laboratory to Target Protein Associated with Parkinson's Disease

  3/22/2018

  Research Collaboration Focuses on United Neuroscience "Endobody" Technology Directed Against Pathogenic Forms of Alpha-Synuclein Protein

• United Neuroscience to Present at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics

  2/28/2018

  United Neuroscience, Ltd., (UNS), today announced that the company will present at the upcoming 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT) conference being held March 7-10, 2018.

• United Neuroscience Announces Development Plans for Vaccine to Prevent CTE

  1/29/2018

  As part of the program introduction, Dr. Verma and NFL broadcaster Solomon Wilcots will discuss the medical need and opportunity for the CTE vaccine program with journalists Jan. 30-31 on Super Bowl Radio Row in Minneapolis.